Moreover, sitagliptin and liraglutide (a GLP-1 receptor agonist) were shown to be effective in reducing the phosphorylation of tau, a toxic mediator of retinal ganglion cell synaptic neurodegeneration, underlying the important role of correct synaptic connectivity in order to prevent retinal degeneration in DR [131]. Here, MAPT is linked to retinal degeneration.